Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY

v3.21.1
CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit
Total
Common Stock, Shares, Outstanding period beginning at Feb. 03, 2018 6,529,045      
Total Shareholders' Equity period beginning at Feb. 03, 2018 $ 65,000 $ 439,699,000 $ (355,768,000) $ 83,996,000
Net income (loss) $ 0 0 (22,157,000) (22,157,000)
Common stock issuances pursuant to equity compensation awards, Shares 262,889      
Common stock issuances pursuant to equity compensation awards, Value $ 3,000 45,000 0 48,000
Share-based payment compensation $ 0 3,064,000 0 3,064,000
Common Stock, Shares, Outstanding period end at Feb. 02, 2019 6,791,934      
Total Shareholders' Equity period end at Feb. 02, 2019 $ 68,000 442,808,000 (377,925,000) 64,951,000
Net income (loss) $ 0 0 (56,296,000) (56,296,000)
Common stock issuances pursuant to equity compensation awards, Shares 225,293      
Common stock issuances pursuant to equity compensation awards, Value $ 2,000 (41,000) 0 (39,000)
Share-based payment compensation $ 0 2,204,000 0 2,204,000
Common stock issuances pursuant to business acquisitions, Shares 391,000      
Common stock issuances pursuant to business acquisitions, Value $ 4,000 1,852,000 0 1,856,000
Common stock and warrant issuance , Shares 800,000      
Common stock and warrant issuance, Value $ 8,000 6,010,000 0 $ 6,018,000
Common Stock, Shares, Outstanding period end at Feb. 01, 2020 8,208,227     8,208,227
Total Shareholders' Equity period end at Feb. 01, 2020 $ 82,000 452,833,000 (434,221,000) $ 18,694,000
Net income (loss) $ 0 0 (13,234,000) (13,234,000)
Common stock issuances pursuant to equity compensation awards, Shares 99,822      
Common stock issuances pursuant to equity compensation awards, Value $ 1,000 (14,000) 0 (13,000)
Share-based payment compensation $ 0 1,960,000 0 1,960,000
Common stock and warrant issuance , Shares 4,596,314      
Common stock and warrant issuance, Value $ 46,000 19,597,000 0 $ 19,643,000
Exercise of warrants,Shares 114,698      
Exercise of warrants,Value $ 1,000 (1,000) 0  
Common Stock, Shares, Outstanding period end at Jan. 30, 2021 13,019,061     13,019,061
Total Shareholders' Equity period end at Jan. 30, 2021 $ 130,000 $ 474,375,000 $ (447,455,000) $ 27,050,000